Engineered Toll-like Receptor Nanoagonist Binding to Extracellular Matrix Elicits Safe and Robust Antitumor Immunity-Reference-Cited by-同舟云学术

Engineered Toll-like Receptor Nanoagonist Binding to Extracellular Matrix Elicits Safe and Robust Antitumor Immunity

Published:2023-03-13 Issue:6 Volume:17 Page:5340-5353
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Yang Liu¹,Lang Yue²,Wu Haoguang¹,Xiang Kaiyan¹,Wang Yuanzheng¹,Yu Mengqi³⁴,Liu Yu¹,Yang Bowei³⁴,He Liangcan⁵^ORCID,Lu Guangming¹^ORCID,Ni Qianqian¹⁴⁶,Chen Xiaoyuan³⁴⁶⁷^ORCID,Zhang Longjiang¹

Affiliation:

1. Department of Radiology, Jinling Hospital, Medical School of Nanjing University, Nanjing, 210002 Jiangsu, China

2. National Clinical Research Center of Kidney Diseases, Jinling Hospital, Medical School of Nanjing University, Nanjing, 210002 Jiangsu, China

3. Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore

4. Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore

5. School of Medicine and Health, Harbin Institute of Technology, Harbin 150080, China

6. Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore

7. Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A*STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore

Funder

Ministry of Science and Technology of the People's Republic of China

National Medical Research Council

Natural Science Foundation of Jiangsu Province

National University of Singapore

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.2c08429